Filing Flows › ASP Isotopes (ASPI) › Q4 2024
ASP Isotopes (ASPI) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 31, 2025
ASP Isotopes (ASPI) reported revenue of $1.2M for the fourth quarter 2024 (Q4 2024), +176% from a year earlier and +10% from the quarter before. Operating margin was -640.7%, net loss $9.2M (772.5% of revenue).
ASP Isotopes, Q4 2024: revenue $1.2M (+176% year over year), operating margin -640.7%, net loss $9.2M, operating cash flow −$3.8M. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | +10% | +176% |
| Operating profit | −$7.6M | — | — |
| Net earnings | −$9.2M | — | — |
| Operating cash flow | −$3.8M | — | — |
What changed
Revenue was $1.2M in Q4 2024, up 176% year over year and up 10% from the previous quarter.
Gross margin was 50.7%, up 18.6 points from a year earlier. Operating costs exceeded revenue by $7.6M, an operating margin of -640.7%. Operating expenses grew 98% against revenue growth of 176%. The fastest-growing cost line was Research & development (+2073%). The quarter ended with a net loss of $9.2M, wider than the previous quarter's $7.4M loss.
Operating cash flow was −$3.8M. Non-cash charges added back $45K of depreciation and amortization and $2.3M of share-based compensation. Working capital and other items added $3.2M. Capital expenditures of $1.3M exceeded it, leaving free cash flow of −$5.1M.
Questions
What was ASP Isotopes' revenue in the fourth quarter 2024?
ASP Isotopes (ASPI) reported revenue of $1.2M for the fourth quarter 2024 (Q4 2024), +176% from a year earlier and +10% from the quarter before.
Was ASP Isotopes profitable in the fourth quarter 2024?
Operating loss was $7.6M (-640.7% of revenue) and net loss $9.2M.
Source: ASP Isotopes 10-K on SEC EDGAR.